PMID 12839249
For description of ARNA response to intrapelvic injection of GLP-1 (3 M in saline, Enzo Life science, Farmingdale, NY), ARNA was expressed as a percent changes from the baseline value and also normalized to maximal ARNA induced by intrapelvic injection of capsaicin (100 M in 5% ethanol and 95% saline, Sigma, Saint Louis, MO) thus expressed as a percent of ARNAmax as shown previously [24, 26, 34]
Weeks 13 and beyond: full therapeutic effect At 12mg weekly maintenance, you are at the dose that produced the headlines
There have been several,posts recently from people struggling in the same way and B12 deficiency / PA is so complex that it's quite difficult to sort out what's going on
FDA-Compliant Peptide Selection Your provider should: Exclusively offer FDA-approved peptides or those compoundable under current FDA policy Refuse to prescribe non-approved compounds like Explain FDA approval status and off-label use when relevant Update protocols as FDA guidance changes Ask directly: Do you prescribe (insert research grade non-human peptide name) ? If the answer is yes, find a different provider
